Chemotherapy_Regimen_Has_Component
R-ESHAP Regimen
A regimen consisting of rituximab, etoposide, methylprednisolone, high-dose cytarabine and cisplatin that can be used in the treatment of Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL).
C140099
CL538185
Etoposide/Methylprednisolone/High-dose Cytarabine/Cisplatin
R-ESHAP
R-ESHAP Regimen
R-ESHAP Regimen
Rituximab-Etoposide-Methylprednisolone-High-dose Cytarabine-Cisplatin
Rituximab-Etoposide-Solu-Medrol-High-dose Ara-C-Platinol
Rituximab/Etoposide/Solumedrol/High-dose Cytarabine/Cisplatin
Therapeutic or Preventive Procedure
Pharmacotherapy Regimens
Multi-agent Therapeutic Regimens
Rituximab
Cisplatin
Cytarabine
Etoposide
Regimen Used to Treat Hodgkin Lymphoma
Regimen Used to Treat Non-Hodgkin Lymphoma
Methylprednisolone